These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26895488)

  • 21. Thyroid Remnant Estimation by Diagnostic Dose (131)I Scintigraphy or (99m)TcO4(-) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131)I Imaging.
    Liu G; Li N; Li X; Chen S; Du B; Li Y
    Biomed Res Int; 2016; 2016():4763824. PubMed ID: 27034938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
    Chantadisai M; Kingpetch K
    Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer.
    Caglar M; Tuncel M; Alpar R
    Ann Nucl Med; 2004 Sep; 18(6):479-82. PubMed ID: 15515746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer.
    Lee SW; Lee J; Lee HJ; Seo JH; Kang SM; Bae JH; Ahn BC
    Thyroid; 2007 Apr; 17(4):341-6. PubMed ID: 17465864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
    Campbell CM; Khafagi FA
    Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of recombinant human thyrotropin-stimulated ¹²³I whole-body scintigraphy in the follow-up of patients with differentiated thyroid cancer.
    Alzahrani AS; AlShaikh O; Tuli M; Al-Sugair A; Alamawi R; Al-Rasheed MM
    Clin Nucl Med; 2012 Mar; 37(3):229-34. PubMed ID: 22310247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.
    Caglar M; Bozkurt FM; Akca CK; Vargol SE; Bayraktar M; Ugur O; Karaağaoğlu E
    Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma probe (99m)Tc-pertechnetate assisted completion thyroidectomy vs conventional thyroidectomy in differentiated thyroid carcinoma.
    Bender O; Karyagar S; Levent Balci F; Yuney E; Kamali S; Ozpacaci T; Mulazimoglu M; Uyanik E; Karyagar SS; Sari YS
    Hell J Nucl Med; 2009; 12(2):138-41. PubMed ID: 19675867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine-needle aspiration cytology and (99m)Tc-pertechnetate scintigraphy together in patients with differentiated thyroid carcinoma.
    Lumachi F; Fabbro M; Tregnaghi A; Antunovic L; Bui F; Cecchin D; Zucchetta P; Fassina A
    Anticancer Res; 2010 Jul; 30(7):3083-6. PubMed ID: 20683059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning.
    Wei JP; Burke GJ
    Ann Surg Oncol; 1995 May; 2(3):233-7. PubMed ID: 7641020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK; Nwoke F; Goldfarb RC; Ongseng F
    Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
    Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
    Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131.
    Khammash NF; Halkar RK; Abdel-Dayem HM
    Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents.
    Kiratli PO; Kara PP; Ergün EL; Gedikoğlu G
    Ann Nucl Med; 2004 Jul; 18(5):443-6. PubMed ID: 15462407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased uptake on I-131 whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy.
    Caglar M; Tuncel M; Usubutun A
    Clin Nucl Med; 2003 Nov; 28(11):945-6. PubMed ID: 14578721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET performed concurrently with initial I-131 ablation for differentiated thyroid cancer.
    Iwano S; Kato K; Ito S; Tsuchiya K; Naganawa S
    Ann Nucl Med; 2012 Apr; 26(3):207-13. PubMed ID: 22160654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.